Bifenthrin Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

Ortho is the best-performing bifenthrin brand in July 2026, moving 105,000 units across 5 ASINs for 64.8% of Top 10 volume. Atticus follows with 20,000 units (12.3%), ahead of Bonide on 17,000 units (10.5%).

With 5 brands splitting the Top 10 and 87.7% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $11.48 to $26.99, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, 2 ASINs forced its way in: B09BCLTQ7S booked 10K units at $24.99, with ▲ 25.0% MoM change. On the growth side, B0D6SMZ76P leads positive momentum with ▲ 150.0% MoM growth on 5K units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.